Aroa Biosurgery Ltd (ARX) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.64 Million ≈ $2.58 Million USD) by net assets (AU$80.93 Million ≈ $57.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ARX net asset quality index to measure how much of total assets are equity-financed.

Aroa Biosurgery Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Aroa Biosurgery Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Aroa Biosurgery Ltd (ARX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Aroa Biosurgery Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aroa Biosurgery Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CVC Ltd AU:CVC	-0.098x
Ajiya Bhd KLSE:7609	-0.020x
TuHURA Biosciences Inc NASDAQ:HURA	-0.190x
Ya Horng Electronic Co Ltd TW:6201	0.023x
Seven West Media Ltd AU:SWM	-0.001x
Wah Seong Corporation Bhd KLSE:5142	0.056x
Yg Plus Inc KO:037270	0.143x
Wasko S.A. WAR:WAS	0.045x

Annual Cash Flow Conversion Efficiency for Aroa Biosurgery Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Aroa Biosurgery Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Aroa Biosurgery Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	AU$84.59 Million ≈ $59.85 Million	AU$-2.33 Million ≈ $-1.65 Million	-0.028x	+64.51%
2024-03-31	AU$87.09 Million ≈ $61.62 Million	AU$-6.76 Million ≈ $-4.79 Million	-0.078x	-109.81%
2023-03-31	AU$95.38 Million ≈ $67.49 Million	AU$-3.53 Million ≈ $-2.50 Million	-0.037x	+67.71%
2022-03-31	AU$93.40 Million ≈ $66.09 Million	AU$-10.71 Million ≈ $-7.58 Million	-0.115x	-22.95%
2021-03-31	AU$53.69 Million ≈ $37.99 Million	AU$-5.01 Million ≈ $-3.54 Million	-0.093x	-471.64%
2020-03-31	AU$62.86 Million ≈ $44.48 Million	AU$1.58 Million ≈ $1.12 Million	0.025x	+4523.65%
2019-03-31	AU$11.52 Million ≈ $8.15 Million	AU$-6.54K ≈ $-4.62K	-0.001x	+99.96%
2018-03-31	AU$1.77 Million ≈ $1.25 Million	AU$-2.80 Million ≈ $-1.98 Million	-1.586x	-1251.70%
2017-03-31	AU$6.28 Million ≈ $4.44 Million	AU$-737.06K ≈ $-521.52K	-0.117x	-70.03%
2016-03-31	AU$5.91 Million ≈ $4.18 Million	AU$-408.04K ≈ $-288.71K	-0.069x	+64.65%
2015-03-31	AU$6.92 Million ≈ $4.90 Million	AU$-1.35 Million ≈ $-956.64K	-0.195x	-8.88%
2014-03-31	AU$7.58 Million ≈ $5.36 Million	AU$-1.36 Million ≈ $-961.75K	-0.179x	--

About Aroa Biosurgery Ltd

AU:ARX Australia Medical Devices

Market Cap

$136.17 Million

AU$192.45 Million AUD

Market Cap Rank

#17965 Global

#537 in Australia

Share Price

AU$0.56

Change (1 day)

-2.63%

52-Week Range

AU$0.51 - AU$0.80

All Time High

AU$1.54